CE Mark granted to the Hugo™ Robotic-Assisted Surgery System by Medtronic
Medical technology leader Medtronic plc announced today the Hugo robotic-assisted surgery (RAS) system has received the CE (Conformité Européenne) Mark. The CE mark enables the system to be sold by Medtronic in Europe.
About half of all robotic surgeries today are urological and gynaecological, which are now CE marked.
Megan Rosengarten, the president of the Surgical Robotics business segment of Medtonic’s Medical Surgical Portfolio, had this to say in a press statement:
“This day has been a long time coming, not just for Medtronic, but for the surgeons and hospital leaders who have partnered with us on this journey to bring the benefits of robotic-assisted surgery to more patients around the world. We know our solution is more meaningful because of their insights. With the Hugo RAS system in our European customers’ hands and our dedicated team by their side, together we will redefine what is possible in robotic-assisted surgery.”
Since robotic surgery adoption has been stifled for two decades because of high costs and low utilization, Hugo RAS addresses these issues.
Around the world, only around 3% of surgeries are performed by robots, despite robotic surgery offering patients the benefits which minimally invasive surgery offers, such as fewer complications, shorter stays in hospital, and a more rapid return to normal, everyday life. Only 2% of procedures are performed robotically in Western Europe, with the majority (around 65%) being performed as open surgery, with the remainder falling into the category of minimally invasive surgery.
Rob Ten Hoedt, the executive vice president and president of the Europe, Middle East, and Africa (EMEA) segment at Medtronic, said this:
“Robotics and artificial intelligence are the undeniable future of healthcare, with incredible potential to not only advance patient care, but increase access to these benefits. The Hugo RAS system builds on our leadership in minimally invasive surgery, and we’re thrilled to provide hospitals across Europe a robotic-assisted surgery system that is thoughtfully designed to meet their needs today and tomorrow. We’ve had strong interest from leading surgical centers across Europe and expect to move quickly with multiple installations in several countries.”
These hospitals with become some of the first in Europe in joining Medtronic’s program Partners In Possibility, which is a collective of pioneering institutions which will be among the world’s first in using the Hugo RAS system, as well as participating in the global patient registry.
Employees of these hospitals will also be set up with hands-on type training at Medtronic’s Surgical Robotics Experience Centers, which additionally include two leading partner sites – which are Ghent’s ORSI Academy, located in Belgium, as well as IRCAD in Strasbourg in France.